At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
06132 HJ SCIENCE-B
Closed 10-14 16:08:24
32.260
-2.000
-5.84%
High35.180
Low32.200
Vol173.60K
Open33.180
D1 Closing34.260
Amplitude8.70%
Mkt Cap2.37B
Tradable Cap2.37B
Total Shares73.60M
T/O5.82M
T/O Rate0.24%
Tradable Shares73.60M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
HJ Science Posts Wider H1 2026 Loss Despite Doubling Revenue; IPO Lifts Cash to RMB 1.11 Billion
HJ Science Co Ltd is a China-based company primarily engaged in the research and development of new small molecule drugs. The Company's main products include the selective tyrosine kinase 2 (TYK2) inhibitor HJ787, the orally administered drug HJ178, the orally administered Kirsten rat sarcoma 2 viral oncogene homolog G12C inhibitor HJ891, as well as drug candidates HJ197, HJ356, HJ093, and HJ199. The products are primarily used to treat various autoimmune diseases, type 2 diabetes, overweight or obesity, cardiovascular diseases and atherosclerosis, non-small cell lung cancer (NSCLC), and advanced hepatocellular carcinoma (HCC). The Company primarily operates its business in the domestic market.